OBJECTIVES: To describe the prevalence of depressive symptoms in adolescents presenting to the emergency department (ED) and to describe their demographics and outcomes compared with adolescents endorsing low levels of depressive symptoms. METHODS: The Beck Depression Inventory-2nd edition (BDI-II) was used to screen all patients 13-19 years of age who presented to the ED during the period of study. The BDI-II is a 21-item self-report instrument used to measure the presence and severity of depressive symptoms in adolescents and adults. Demographics and clinical outcomes of screening-program participants were abstracted by chart review. Patients were categorized into one of four severity categories (minimal, mild, moderate, or severe) and one of three presenting complaint categories (medical, trauma, mental health). RESULTS: Four hundred eighty-seven patients were approached, and 351(72%) completed the screening protocol. Participants endorsed minimal (n = 192, 55%), mild (n = 52, 15%), moderate (n = 41, 11%), or severe depressive symptoms (n = 66, 19%). Those with moderate or severe depressive symptoms were more likely to be hospitalized. Of patients completing the BDI-II, 72% with psychiatric, 12% with traumatic, and 19% with medical chief complaints endorsed either moderate or severe depressive symptoms. CONCLUSIONS: Depressive symptoms are prevalent in this screening sample, regardless of presenting complaint. A substantial proportion of patients with nonpsychiatric chief complaints endorsed moderate or severe depressive symptoms. A screening program might allow earlier identification and referral of patients at risk for depression.
OBJECTIVES: To describe the prevalence of depressive symptoms in adolescents presenting to the emergency department (ED) and to describe their demographics and outcomes compared with adolescents endorsing low levels of depressive symptoms. METHODS: The Beck Depression Inventory-2nd edition (BDI-II) was used to screen all patients 13-19 years of age who presented to the ED during the period of study. The BDI-II is a 21-item self-report instrument used to measure the presence and severity of depressive symptoms in adolescents and adults. Demographics and clinical outcomes of screening-program participants were abstracted by chart review. Patients were categorized into one of four severity categories (minimal, mild, moderate, or severe) and one of three presenting complaint categories (medical, trauma, mental health). RESULTS: Four hundred eighty-seven patients were approached, and 351(72%) completed the screening protocol. Participants endorsed minimal (n = 192, 55%), mild (n = 52, 15%), moderate (n = 41, 11%), or severe depressive symptoms (n = 66, 19%). Those with moderate or severe depressive symptoms were more likely to be hospitalized. Of patients completing the BDI-II, 72% with psychiatric, 12% with traumatic, and 19% with medical chief complaints endorsed either moderate or severe depressive symptoms. CONCLUSIONS:Depressive symptoms are prevalent in this screening sample, regardless of presenting complaint. A substantial proportion of patients with nonpsychiatric chief complaints endorsed moderate or severe depressive symptoms. A screening program might allow earlier identification and referral of patients at risk for depression.
Authors: Luther G Kalb; Emma K Stapp; Elizabeth D Ballard; Calliope Holingue; Amy Keefer; Anne Riley Journal: Pediatrics Date: 2019-03-18 Impact factor: 7.124
Authors: Megan L Ranney; John V Patena; Shira Dunsiger; Anthony Spirito; Rebecca M Cunningham; Edward Boyer; Nicole R Nugent Journal: Contemp Clin Trials Date: 2019-05-23 Impact factor: 2.226
Authors: Anthony Spirito; Julie R Bromberg; T Charles Casper; Thomas Chun; Michael J Mello; Colette C Mull; Rohit P Shenoi; Cheryl Vance; Fahd Ahmad; Lalit Bajaj; Kathleen M Brown; Lauren S Chernick; Daniel M Cohen; Joel Fein; Timothy Horeczko; Michael N Levas; B McAninch; Michael C Monuteaux; Jackie Grupp-Phelan; Elizabeth C Powell; Alexander Rogers; Brian Suffoletto; James G Linakis Journal: Subst Use Misuse Date: 2019-02-06 Impact factor: 2.164
Authors: Punit Virk; Samara Laskin; Rebecca Gokiert; Chris Richardson; Mandi Newton; Rob Stenstrom; Bruce Wright; Tyler Black; Quynh Doan Journal: BMJ Paediatr Open Date: 2019-07-24